![Courtenay C. Brinckerhoff, intellectual property law attorney, Foley & Lardner Law Firm](https://www.natlawreview.com/sites/default/files/styles/author_profile/public/images/CB.jpg?itok=8avFnppT)
Courtenay Brinckerhoff is a partner and intellectual property lawyer with Foley & Lardner LLP. Ms. Brinckerhoff’s practice focuses on client counseling in all aspects of obtaining, licensing and enforcing patents and conducting freedom-to-operate and due diligence investigations. She is chair of the firm’s IP Law and Practice committee, immediate past vice chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and a member of the firm's Patent Trials group, Appellate Practice and Life Sciences Industry Team. She also is involved with Foley’s Medical Device Initiative and Nutraceuticals Team. Ms. Brinckerhoff is the editor and primary author for Foley’s PharmaPatentsBlog.com.
Over the past 20 years, Ms. Brinckerhoff has represented clients before the U.S. Patent Office, the Patent Trial and Appeal Board, and the U.S. Court of Appeals for the Federal Circuit, and has been involved in complex patent matters, including a four-party interference, Inter Partes Reexaminations, Inter Partes Reviews, and ANDA litigation.
Ms. Brinckerhoff works with clients in diverse industries, including pharmaceuticals (chemical and biotechnological), human and animal food products, nutraceuticals, and medical devices. She has particular experience with transdermal pharmaceutical products (patches, gels, and liquids), oral dosage forms (including controlled/extended release formulations), enzyme-based technologies, diagnostic and therapeutic antibodies, active and passive immunization therapies, and personalized medicine.
She has served as vice chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and is an active member of the firm's Appellate Practice and Life Sciences Industry Team.
More Legal and Business Bylines From Courtenay C. Brinckerhoff
- Federal Circuit Hears Oral Arguments in Neupogen Biosimilar Case - (Posted On Thursday, June 04, 2015)
- Another Sequenom Patent Appeal Heads To The Federal Circuit - (Posted On Tuesday, June 02, 2015)
- Dependent Claims Give Rise To Improper Broadening Reissue re: Patent Applications - (Posted On Wednesday, May 27, 2015)
- Patent Safe Harbor Applies To Supplemental New Drug Applications - (Posted On Thursday, May 21, 2015)
- Federal Circuit Finds No Direct Infringement Of Akamai Patents - (Posted On Tuesday, May 19, 2015)
- First Look At False Marking Under The AIA - America Invents Act - (Posted On Thursday, May 14, 2015)
- California Supreme Court Scrutinizes Reverse Payment ANDA Settlements - (Posted On Tuesday, May 12, 2015)
- Federal Circuit Keeps Sandoz Biosimilar Off The Market For Now - (Posted On Wednesday, May 06, 2015)
- Keeping Up With Kyle Bass: Pharma Patents Post - (Posted On Tuesday, May 05, 2015)
- Why the Grace Period Restoration Act Is a Bad Idea - (Posted On Thursday, April 30, 2015)
Courtenay C. Brinckerhoff and her work on Foley & Lardner's Pharma Patents blog has been selected for a National Law Review Go-To Thought Leadership Award. Ms. Brinckerhoff offers expert analysis on an area of law that can be very complicated, breaking down developments at the U.S. Patent Office, the Patent Trial and Appeal Board, and the U.S. Court of Appeals for the Federal Circuit. Her insights on patent litigation, especially pharmaceutical patents, and how decisions impact the larger landscape are of particular interest to our readers. You can subscribe to Foley & Lardner's blog, PharmaPatents, here.